Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges.

Katzenschlager, R; Hughes, A; Evans, A; Manson, AJ; Hoffman, M; Swinn, L; Watt, H; Bhatia, K; Quinn, N; Lees, AJ; (2004) Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges. Movement disorders, 20 (2). pp. 151-7. ISSN 0885-3185 DOI: https://doi.org/10.1002/mds.20276

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/mds.20276

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar